3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Interventions
Epoetin Alfa
8
ferric carboxymaltose
6
epoetin beta
6
Meropenem
6
Ceftazidime
5
Vancomycin
4
Darbepoetin alfa
4
apixaban
3
Enoxaparin
3
Ciprofloxacin
3
Cefepime
3
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
Teicoplanin
2
Radiotherapy
2
Levofloxacin
2
Filgrastim
2
Dalteparin
2
Cholecalciferol
2
Aspirin
2
Amikacin
2
sotorasib
1
posaconazole
1
ferrous succinate
1
ferric gluconate
1
eltrombopag
1
ceftolozane, tazobactam drug combination
1
Vitamin B 12
1
Vaccination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pharmacokinetics
×
Classical hematology
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled